$18.04
▼ -0.2% Today
as of Sep 4, 16:46 ET
Last 30 days
Recent Press Releases & News
Bausch + Lomb Announces New Published Research on enVista Aspire™ Real World Experience
Bausch + Lomb (BLCO) Stock Trades Below Fair Value As Caution Lingers
Bausch + Lomb Advances Two First-in-Class Eye Health Therapies
Overview
52-week range
$14
$19
83% of range
Avg surprise (last 2)
-158.3%
Avg reaction (last 1)
-15.7%
0% positive
Latest IV / EM
110%
EM ±17.2% · $18 · Sep 18
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Tue Jun 30, 2026 | Jun 2026 | $-0.04 | — | — | — | — | financials |
| Tue Mar 31, 2026 | Mar 2026 | $-0.20 | — | — | — | — | financials |
| Tue Sep 30, 2025 | Sep 2025 | $-0.08 | — | — | — | — | financials |
| Wed Jul 30, 2025 | Jun/2025 | $0.07 | $0.06 | +16.7% | — | — | earnings |
| Wed Apr 30, 2025 | Mar/2025 | $-0.07 | $0.03 | -333.3% | — | -15.7% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $0.01 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $-0.43 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $-0.48 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $-0.24 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $-0.09 | — | — | — | — | financials |
| Fri Mar 31, 2023 | Mar 2023 | $-0.26 | — | — | — | — | financials |
Financials
Income statement (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.39B | $1.24B | — | $1.28B | $1.28B | $1.14B | — | $1.20B |
| Cost of revenue | — | — | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $83M | $33M | — | $95M | $-11M | $-83M | — | $43M |
| Net income | $-14M | $-71M | — | $-28M | $-62M | $-212M | — | $4M |
| EPS (diluted) | $-0.04 | $-0.20 | — | $-0.08 | $-0.18 | $-0.60 | — | $0.01 |
Balance sheet (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $367M | $268M | $383M | $310M | $266M | $202M | $305M | $329M |
| Inventory | $999M | $977M | $976M | $1.00B | $1.05B | $1.03B | $1.04B | $1.12B |
| Total current assets | $2.92B | $2.78B | $2.98B | $2.85B | $2.85B | $2.69B | $2.79B | $2.83B |
| Total assets | $13.86B | $13.78B | $14.02B | $13.83B | $13.83B | $13.43B | $13.47B | $13.52B |
| Long-term debt | $5.05B | $5.01B | $5.02B | $4.92B | $4.93B | $4.79B | $4.74B | $4.60B |
| Total liabilities | $7.42B | $7.33B | $7.50B | $7.33B | $7.32B | $7.00B | $6.92B | $6.85B |
| Total equity | $6.38B | $6.45B | $6.45B | $6.43B | $6.51B | $6.43B | $6.47B | $6.66B |